Towards a Beating Cardiovascular Disease Plan for Europe

Getting to the heart of the matter

Tuesday, 28 September 2021 | 13:00-14:30 | Room 1

Organised by Amgen

Despite improvements over the past decade, cardiovascular disease (CVD) remains the leading cause of death in Europe. With an ageing population and vast disparities in morbidity and mortality within and across countries in Europe, it is already evident that the burden of CVD may be on a downward turn. Already some countries are seeing increases in incidence, prevalence and mortality compared to previous years. The impact of comorbidities like CVD and other cardiometabolic diseases on COVID-19 outcomes are also emerging as a key health determinant. 

Now is the time to act to ensure health systems return to a focus on CVD as a critical health issue and demonstrate decisive action to improve the many modifiable risks that exist. Now is the time to mobilize and connect CVD stakeholders in creating an effective platform for Europe to raise CVD higher on health policy agendas.

Join us in this interactive session to explore how we can build on the joint statement calling on the EU to develop a comprehensive plan on CVD, conceptualize new CVD partnership models, address the future continuity of care for patients, mitigate the impact of the secondary health crisis, and challenge existing inequalities as we seek to set out a new policy vision for CVD.

Session Recording

Speakers & panellists

Moderated by

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kurgartenstraße, 5630 Bad Hofgastein, Austria